secwatch.observer — SEC 8-K summary
======================================

Issuer:     Indaptus Therapeutics, Inc. (INDP)
CIK:        0001857044
Form:       8-K/A
Filed at:   2026-09-05T01:55:25+00:00
Accession:  0001493152-26-041636
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Indaptus enters $100M ATM equity offering agreement with H.C. Wainwright
------------------------------------------------------------------------

- Amended and restated ATM agreement executed Aug 28, 2026, replacing June 1, 2022 pact with H.C. Wainwright.
- Company may sell up to $100M in common stock through Wainwright as sales agent or principal.
- Placement fee of 3.0% of gross sales proceeds for agent sales; no obligation to sell any shares.
- Prospectus supplement filed Aug 31, 2026, amended Sept 4, 2026 to update dilution disclosure.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1857044/000149315226041636/0001493152-26-041636-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1857044/000149315226041636/form8-ka.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-041636

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer